Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia.

Pitt-Hopkins syndrome autism basic helix-loop-helix transcription factor intellectual disability missense mutation neurocognitive disorders neuron schizophrenia single-nucleotide polymorphism transcription factor TCF4

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
12 2021
Historique:
received: 06 08 2021
revised: 28 10 2021
accepted: 30 10 2021
pubmed: 9 11 2021
medline: 27 1 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

Transcription factor 4 (TCF4) is a basic helix-loop-helix transcription factor essential for neurocognitive development. The aberrations in TCF4 are associated with neurodevelopmental disorders including schizophrenia, intellectual disability, and Pitt-Hopkins syndrome, an autism-spectrum disorder characterized by developmental delay. Several disease-associated missense mutations in TCF4 have been shown to interfere with TCF4 function, but for many mutations, the impact remains undefined. Here, we tested the effects of 12 functionally uncharacterized disease-associated missense mutations and variations in TCF4 using transient expression in mammalian cells, confocal imaging, in vitro DNA-binding assays, and reporter assays. We show that Pitt-Hopkins syndrome-associated missense mutations within the basic helix-loop-helix domain of TCF4 and a Rett-like syndrome-associated mutation in a transcription activation domain result in altered DNA-binding and transcriptional activity of the protein. Some of the missense variations found in schizophrenia patients slightly increase TCF4 transcriptional activity, whereas no effects were detected for missense mutations linked to mild intellectual disability. We in addition find that the outcomes of several disease-related mutations are affected by cell type, TCF4 isoform, and dimerization partner, suggesting that the effects of TCF4 mutations are context-dependent. Together with previous work, this study provides a basis for the interpretation of the functional consequences of TCF4 missense variants.

Identifiants

pubmed: 34748727
pii: S0021-9258(21)01187-X
doi: 10.1016/j.jbc.2021.101381
pmc: PMC8648840
pii:
doi:

Substances chimiques

TCF4 protein, human 0
Tcf4 protein, rat 0
Transcription Factor 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101381

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflict of interest with the contents of the article.

Références

Biol Psychiatry. 2010 Jul 1;68(1):33-40
pubmed: 20434134
Nature. 2009 Aug 6;460(7256):744-7
pubmed: 19571808
J Biol Chem. 1996 Jul 26;271(30):17733-8
pubmed: 8663468
Curr Opin Cell Biol. 2008 Jun;20(3):253-9
pubmed: 18436437
J Neurosci. 2018 Jan 24;38(4):918-936
pubmed: 29222403
Hum Mutat. 2009 Apr;30(4):669-76
pubmed: 19235238
J Biol Chem. 2002 Feb 22;277(8):6469-77
pubmed: 11724804
Am J Med Genet A. 2008 Aug 15;146A(16):2053-9
pubmed: 18627065
Hum Mol Genet. 2011 Oct 15;20(20):4076-81
pubmed: 21791550
Front Neuroanat. 2020 Jul 17;14:42
pubmed: 32765228
Clin Genet. 2019 Apr;95(4):462-478
pubmed: 30677142
Am J Med Genet A. 2012 Jul;158A(7):1604-11
pubmed: 22678594
J Neurosci. 2017 Oct 25;37(43):10516-10527
pubmed: 28951451
Dis Model Mech. 2020 Jul 30;13(7):
pubmed: 32641419
Cell Mol Life Sci. 2014 Aug;71(15):2815-35
pubmed: 24413739
Neurogenetics. 2018 Jan;19(1):41-47
pubmed: 29322350
PLoS Genet. 2014 Oct 30;10(10):e1004772
pubmed: 25356899
PLoS One. 2013 Aug 23;8(8):e73169
pubmed: 24058414
Nat Genet. 2011 Sep 18;43(10):969-76
pubmed: 21926974
Mol Cell Biol. 2000 Jan;20(2):429-40
pubmed: 10611221
Bioinformatics. 2014 Oct 15;30(20):2981-2
pubmed: 24996895
Am J Hum Genet. 2007 May;80(5):994-1001
pubmed: 17436255
Cancer Cell. 2014 Mar 17;25(3):393-405
pubmed: 24651015
Hum Mutat. 2012 Dec;33(12):1676-86
pubmed: 22777675
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Sci Adv. 2019 Sep 11;5(9):eaau4139
pubmed: 31535015
Sci Rep. 2019 Oct 30;9(1):15629
pubmed: 31666615
Hum Mol Genet. 2012 Jul 1;21(13):2873-88
pubmed: 22460224
Biochem Biophys Res Commun. 2008 May 30;370(2):327-31
pubmed: 18371301
Mol Cell Biol. 1996 Jun;16(6):2898-905
pubmed: 8649400
Transl Psychiatry. 2012 May 08;2:e112
pubmed: 22832956
Biochem Biophys Res Commun. 2000 Jul 21;274(1):22-31
pubmed: 10903890
Hum Mol Genet. 2007 Jun 15;16(12):1488-94
pubmed: 17478476
J Med Genet. 2008 Nov;45(11):738-44
pubmed: 18728071
Biol Open. 2015 Nov 30;4(12):1762-71
pubmed: 26621827
Orphanet J Rare Dis. 2016 May 14;11(1):62
pubmed: 27179618
Eur J Med Genet. 2016 Jun;59(6-7):310-4
pubmed: 27132474
J Biol Chem. 1998 Jan 30;273(5):2866-73
pubmed: 9446597
Mol Autism. 2018 Mar 22;9:20
pubmed: 29588831
Hum Mutat. 2012 Jan;33(1):64-72
pubmed: 22045651
Mol Psychiatry. 2018 Feb;23(2):304-315
pubmed: 28289282
Schizophr Bull. 2018 Aug 20;44(5):1100-1110
pubmed: 29228394
Nature. 2009 Aug 6;460(7256):748-52
pubmed: 19571811
Clin Genet. 2013 Feb;83(2):198-200
pubmed: 22670824
EMBO J. 1995 Apr 18;14(8):1766-72
pubmed: 7737127
Genes Dev. 2019 Jan 1;33(1-2):6-25
pubmed: 30602438
Eur J Neurosci. 2020 Jun;51(11):2219-2235
pubmed: 31919899
Front Neurosci. 2014 Nov 06;8:331
pubmed: 25414627
Genes Dev. 2013 Jul 15;27(14):1596-609
pubmed: 23873942
Genes Dev. 2011 May 1;25(9):930-45
pubmed: 21536733
Neural Dev. 2014 Oct 29;9:23
pubmed: 25352248
Neuron. 2016 Apr 6;90(1):43-55
pubmed: 26971948
Trends Cell Biol. 2003 Aug;13(8):410-8
pubmed: 12888293
J Neurosci. 2011 May 4;31(18):6684-91
pubmed: 21543597
J Cell Sci. 2009 Apr 1;122(Pt 7):1014-24
pubmed: 19295128
Mol Psychiatry. 2014 Aug;19(8):857-8
pubmed: 24126932
Am J Med Genet B Neuropsychiatr Genet. 2015 Jul;168B(5):354-62
pubmed: 26010163
J Neurosci. 2020 Feb 12;40(7):1405-1426
pubmed: 31915257
Science. 1985 Jan 11;227(4683):134-40
pubmed: 3917574
Lancet. 2012 Nov 10;380(9854):1674-82
pubmed: 23020937
Cell Rep. 2016 Sep 6;16(10):2666-2685
pubmed: 27568567
Transl Psychiatry. 2020 Oct 9;10(1):343
pubmed: 33037178
PLoS One. 2011;6(7):e22138
pubmed: 21789225
Am J Hum Genet. 2007 May;80(5):988-93
pubmed: 17436254
Transl Psychiatry. 2018 Mar 15;8(1):67
pubmed: 29540662
Clin Genet. 2010 Sep;78(3):282-8
pubmed: 20184619
Acta Neuropathol. 2019 Apr;137(4):657-673
pubmed: 30830316

Auteurs

Alex Sirp (A)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.

Kaisa Roots (K)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.

Kaja Nurm (K)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia.

Jürgen Tuvikene (J)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia; Protobios LLC, Tallinn, Estonia.

Mari Sepp (M)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia. Electronic address: m.sepp@zmbh.uni-heidelberg.de.

Tõnis Timmusk (T)

Department of Chemistry and Biotechnology, Tallinn University of Technology, Tallinn, Estonia; Protobios LLC, Tallinn, Estonia. Electronic address: tonis.timmusk@taltech.ee.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH